Clinical Trials

NCT IdNCT04872101
TitleEfficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)
ConditionChronic Hand Eczema
StudyTypeInterventional
OrganizationLEO Pharma
Sponsor/CollaboratorsLEO Pharma
StatusNot yet recruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
DescriptionThis is a 16-week study in adult participants with chronic hand eczema (CHE). The participants will visit the clinic regularly to have the study doctor assess their CHE and to answer questions about itch, pain, CHE symptoms, and quality of life. The purpose is to assess how delgocitinib cream works to treat CHE when compared to a placebo cream with no active substance.